11 hrs ago
Contact Lens Spectrum
Bausch + Lomb has announced that the U.S. Food and Drug Administration has issued marketing clearance for Biotrue Oneday for Presbyopia soft contact lenses.
Thu Jul 31, 2014
Valeant Pharmaceuticals posts 12-fold rise in net profit
Canada's Valeant Pharmaceuticals International Inc, which is trying to take over Botox-maker Allergan Inc, said net income rose nearly 12-fold, boosted by strong sales at its Bausch & Lomb lens business.
Tue Jul 29, 2014
U.S. Senate panel to look into price setting for contact lenses
Moves by three of the four major U.S. contact lens makers to set price floors for many of their products, preventing low-cost retailers from discounting the expensive devices, have drawn scrutiny from lawmakers.
Mon Jul 21, 2014
Valeant complains about Allergan to U.S., Canadian regulators
Mutual fund firm has consistently dismissed the offer saying it could add more shareholder value independently and that it was weary of Valeant's business model.
Canadian Stocks Fall From Record as Energy Shares Slump
Canadian stocks fell from a record, led by losses in energy companies, amid a retreat in global equities as international pressure on President Vladimir Putin intensified.
Thu Jul 17, 2014
Silicon Alley Insider
This Could Be A Reason Why Valeant Wants To Buy Allergan As Soon As Humanly Possible
On Thursday pharmaceutical company Valeant did yet another presentation meant to sway Allergan shareholders toward a Valeant takeover, and a question at the end of the presentation regarding Basuch & Lomb - which Valeant acquired in May of 2013 - may give us all a clue as to why Valeant is so eager to get this deal done fast.
Mon Jul 14, 2014
Manoj Venkiteshwar Joins TearLab as VP of Medical Affairs
TearLab Corporation today announced the appointment of Manoj S. Venkiteshwar, PhD.
Investor's Business Daily
Allergan Files Investor Presentation
Allergan, Inc. today announced that it has filed an investor presentation with the Securities and Exchange Commission and posted the presentation under the "Investors" section of the Company's website describing "Further Thoughts on Potential Business Risks and Issues with Valeant Pharmaceuticals International, Inc. ."
Tue Jul 08, 2014
Rochester Business Journal
B&L parent acquires PreCision Dermatology
Valeant Pharmaceuticals International Inc. has completed an acquisition of PreCision Dermatology Inc., officials said Tuesday.
Mon Jul 07, 2014
Press release distribution, EDGAR filing, XBRL, regulatory filings
Oslo 2022 aangekondigd als kandidaat-stad; zal trots zijn om bij te dragen tot een verantwoorde ontwikkeling van de Olympische en Paralympische Beweging )--Met de aankondiging van het IOC van Oslo als kandidaat-stad voor 2022, zullen de stad Oslo en het Noorse Olympisch en Paralympisch Comite en de Noorse sportbond --OmniVere today announced the ... (more)
Thu Jul 03, 2014
The Wall Street Journal: Bausch & Lomb recalls about 850,000 tubes of eye ointment
Valeant Pharmaceuticals International Inc.'s Bausch & Lomb unit has recalled at least 850,000 tubes of an eye-care ointment because some tubes contained tiny crystal particles that could injure the cornea.